125 related articles for article (PubMed ID: 22494844)
1. Design and synthesis of 4-O-methylhonokiol analogs as inhibitors of cyclooxygenase-2 (COX-2) and PGF₁ production.
Lee B; Kwak JH; Huang SW; Jang JY; Lim S; Kwak YS; Lee K; Kim HS; Han SB; Hong JT; Lee H; Song S; Seo SY; Jung JK
Bioorg Med Chem; 2012 May; 20(9):2860-8. PubMed ID: 22494844
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of Either C2- or C4'-Alkylated Derivatives of Honokiol and Their Biological Evaluation for Anti-inflammatory Activity.
Lee SH; Fei X; Lee C; Do HTT; Rhee I; Seo SY
Chem Pharm Bull (Tokyo); 2019 Sep; 67(9):966-976. PubMed ID: 31257308
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of ketoprofen analogs as potent cyclooxygenase-2 inhibitors.
Zarghi A; Ghodsi R
Bioorg Med Chem; 2010 Aug; 18(16):5855-60. PubMed ID: 20650641
[TBL] [Abstract][Full Text] [Related]
4. The new 4-O-methylhonokiol analog GS12021 inhibits inflammation and macrophage chemotaxis: role of AMP-activated protein kinase α activation.
Kim S; Ka SO; Lee Y; Park BH; Fei X; Jung JK; Seo SY; Bae EJ
PLoS One; 2015; 10(2):e0117120. PubMed ID: 25706552
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory effect of 4-O-methylhonokiol, compound isolated from Magnolia officinalis through inhibition of NF-kappaB [corrected].
Oh JH; Kang LL; Ban JO; Kim YH; Kim KH; Han SB; Hong JT
Chem Biol Interact; 2009 Aug; 180(3):506-14. PubMed ID: 19539808
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of ten biphenyl-neolignan derivatives and their in vitro inhibitory potency against cyclooxygenase-1/2 activity and 5-lipoxygenase-mediated LTB4-formation.
Schühly W; Hüfner A; Pferschy-Wenzig EM; Prettner E; Adams M; Bodensieck A; Kunert O; Oluwemimo A; Haslinger E; Bauer R
Bioorg Med Chem; 2009 Jul; 17(13):4459-65. PubMed ID: 19481465
[TBL] [Abstract][Full Text] [Related]
7. New Ferrocene Compounds as Selective Cyclooxygenase (COX-2) Inhibitors: Design, Synthesis, Cytotoxicity and Enzyme-inhibitory Activity.
Farzaneh S; Zeinalzadeh E; Daraei B; Shahhosseini S; Zarghi A
Anticancer Agents Med Chem; 2018; 18(2):295-301. PubMed ID: 28971779
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and anti-neuroinflammatory activity of N-heterocyclic analogs based on natural biphenyl-neolignan honokiol.
Yuan Y; Subedi L; Lim D; Jung JK; Kim SY; Seo SY
Bioorg Med Chem Lett; 2019 Jan; 29(2):329-333. PubMed ID: 30472026
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of pyridine acyl sulfonamide derivatives as novel COX-2 inhibitors.
Lu X; Zhang H; Li X; Chen G; Li QS; Luo Y; Ruan BF; Chen XW; Zhu HL
Bioorg Med Chem; 2011 Nov; 19(22):6827-32. PubMed ID: 22000948
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of novel pyrazole–thiadiazole hybrid as potential potent and selective cyclooxygenase-2 (COX-2) inhibitors.
Alegaon SG; Hirpara MB; Alagawadi KR; Hullatti KK; Kashniyal K
Bioorg Med Chem Lett; 2014 Nov; 24(22):5324-9. PubMed ID: 25444084
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of prostaglandin E2 production by synthetic wogonin analogs.
Gurung SK; Kim HP; Park H
Arch Pharm Res; 2009 Nov; 32(11):1503-8. PubMed ID: 20091262
[TBL] [Abstract][Full Text] [Related]
12. Novel acid-type cyclooxygenase-2 inhibitors: Design, synthesis, and structure-activity relationship for anti-inflammatory drug.
Hayashi S; Ueno N; Murase A; Nakagawa Y; Takada J
Eur J Med Chem; 2012 Apr; 50():179-95. PubMed ID: 22373734
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of 1,3-diarylurea derivatives as selective cyclooxygenase (COX-2) inhibitors.
Zarghi A; Kakhgi S; Hadipoor A; Daraee B; Dadrass OG; Hedayati M
Bioorg Med Chem Lett; 2008 Feb; 18(4):1336-9. PubMed ID: 18226898
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of new 2,3-diarylquinoline derivatives as selective cyclooxygenase-2 inhibitors.
Ghodsi R; Zarghi A; Daraei B; Hedayati M
Bioorg Med Chem; 2010 Feb; 18(3):1029-33. PubMed ID: 20061161
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, biological evaluation and molecular modeling of dihydro-pyrazolyl-thiazolinone derivatives as potential COX-2 inhibitors.
Qiu KM; Yan R; Xing M; Wang HH; Cui HE; Gong HB; Zhu HL
Bioorg Med Chem; 2012 Nov; 20(22):6648-54. PubMed ID: 23062711
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of benzimidazole analogs endowed with oxadiazole as selective COX-2 inhibitor.
Rathore A; Rahman MU; Siddiqui AA; Ali A; Shaharyar M
Arch Pharm (Weinheim); 2014 Dec; 347(12):923-35. PubMed ID: 25303727
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and activity of benzothiazole-based inhibitors of NO production in LPS-activated macrophages.
Jin GH; Li H; An S; Ryu JH; Jeon R
Bioorg Med Chem Lett; 2010 Nov; 20(21):6199-202. PubMed ID: 20850309
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological evaluation of 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-indolyl pyrazolines as cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) inhibitors.
Reddy MV; Billa VK; Pallela VR; Mallireddigari MR; Boominathan R; Gabriel JL; Reddy EP
Bioorg Med Chem; 2008 Apr; 16(7):3907-16. PubMed ID: 18272371
[TBL] [Abstract][Full Text] [Related]
19. New selective cyclooxygenase-2 inhibitors from cyclocoumarol: Synthesis, characterization, biological evaluation and molecular modeling.
Rayar AM; Lagarde N; Martin F; Blanchard F; Liagre B; Ferroud C; Zagury JF; Montes M; Sylla-Iyarreta Veitía M
Eur J Med Chem; 2018 Feb; 146():577-587. PubMed ID: 29407982
[TBL] [Abstract][Full Text] [Related]
20. Novel 5-substituted 1H-tetrazoles as cyclooxygenase-2 (COX-2) inhibitors.
Al-Hourani BJ; Sharma SK; Suresh M; Wuest F
Bioorg Med Chem Lett; 2012 Mar; 22(6):2235-8. PubMed ID: 22341941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
